Frontlight ResearchEarly access
TerminatedNo phase
Optimisation of Potential Dental Implant Sites Protection for Rehabilitation in Patients With Head and Neck Cancer: Impact of Virtual Implants Visualisation on Dosimetry (OPPIDOM)
Key facts
- Who runs it
- Institut de cancérologie Strasbourg Europe
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 8 people enrolled
- Started
- 7 May 2021
- Ended
- 17 Jun 2025
- Type of study
- Interventional
- Treatments tested
- Optimisation of dental implant sites protection from irradiation
- Record updated
- 5 January 2026
- Why it stopped
- organisationnal reason
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (12)Hide the full registry criteria
Who can take part
- Patients must be ≥ 18 years old
- Performance Status 0 to 2
- Histologically-confirmed diagnosis of : infiltrating squamous cell carcinoma of the oral cavity or oropharynx
- Indication for an exclusive radiotherapy or post-surgery radiotherapy, with or without chemotherapy
- Indication for a radiotherapy of lymph node areas
- Partial or complete toothlessness requiring rehabilitation
- Signed informed consent from the patient
Who cannot take part
- History of head and neck radiotherapy
- Partial mandibulectomy
- Retarded wound healing or trismus impairing radiological guide preparation
- Patient refusing the study
- Pregnant women
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a monocentric, non-randomized, prospective, in silico feasibility study conducted by Strasbourg Europe Cancerology Institute. The purpose of this study is to evaluate the optimisation of potential dental implant sites protection, without degrading tumor volume coverage, through designation of potential dental implant sites before volume delineation and dosimetry calculations in patients with oropharyngeal or oral cavity squamous cell carcinoma treated by radiotherapy.
The group in the trial
- Patients with oral cavity or oropharyngeal squamous cell carcinomaOther group
Treatment: Optimisation of dental implant sites protection from irradiation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 5 January 2026